ATO confirms tax implications of return of share capital
Filed with ASX · · 6 pages · English
Summary by 6ix AI
PharmX Technologies Limited has announced that the Australian Taxation Office (ATO) has issued a ruling regarding the tax implications of a return of share capital for its shareholders. The ruling confirms that the return of capital payment is not considered a dividend, meaning shareholders will not need to include it in their assessable income. This ruling applies to shareholders registered on a specific date and clarifies the capital gains tax consequences related to the return of capital.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
PharmX Technologies Limited on 6ix
Earlier from PharmX Technologies
- Results for the HY ended 31 Dec 2023
- Appendix 4D and HY Report for 31 Dec 2023
- Response to ASX Price Query
- Notice of Annual General Meeting/Proxy Form
- Completion of sale of pharmacy software business
Later from PharmX Technologies
- Update on Fred Appeals in Legal Proceedings
- FY24 Results
- 2024 Annual Report and Appendix 4E
- Pharmx announces strategic partnership with Toniq
- Half Yearly Report and Accounts
Follow PharmX Technologies into a list and get an email when it puts out news.
Follow PharmX Technologies